- Record: found
- Abstract: not found
- Article: not found
Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial
Pierre Amarenco ,
Gregory W Albers ,
Hans Denison ,
J Donald Easton ,
Scott R Evans ,
Peter Held ,
Michael D Hill ,
Jenny Jonasson ,
Scott E Kasner ,
Per Ladenvall ,
Kazuo Minematsu ,
Carlos A Molina ,
Yongjun Wang ,
K S Lawrence Wong ,
S Claiborne Johnston
April 2017
April 2017
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Ticagrelor is an effective antiplatelet therapy for patients with coronary atherosclerotic
disease and might be more effective than aspirin in preventing recurrent stroke and
cardiovascular events in patients with acute cerebral ischaemia of atherosclerotic
origin. Our aim was to test for a treatment-by-ipsilateral atherosclerotic stenosis
interaction in a subgroup analysis of patients in the Acute Stroke or Transient Ischaemic
Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (SOCRATES) trial.